By Dominic Tyer (European Pharmaceutical Review)2025-09-30T09:23:02
The planned succession will also see him become Chair of the German pharma company’s Executive Board in May 2026.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-06-11T13:00:00
Sponsored by Rapid Micro Biosystems
2025-06-03T13:35:00
Sponsored by bioMérieux, By European Pharmaceutical Review
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
2025-09-19T15:46:00
Sponsored by ACCI, By European Pharmaceutical Review
Site powered by Webvision Cloud